Cognitive · Cognitive peptide (research)
Pinealon
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Also known as
- epd, glu-asp-arg, khavinson peptide, pineal peptide
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Pinealon is studied for
- Neuroprotection (research)
- Cognitive aging research (research)
- Antioxidant activity (research)
Mechanism of action
Pinealon is being studied in the cognitive category. Khavinson tripeptide studied for neuroprotection and cognitive aging. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Pinealon?
Pinealon is a cognitive peptide. Khavinson tripeptide studied for neuroprotection and cognitive aging.
What is Pinealon studied for?
Published research has examined Pinealon for neuroprotection, cognitive aging research, antioxidant activity. Human clinical evidence varies by indication.
Is Pinealon FDA-approved?
No. Pinealon is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Pinealon used in research?
Protocols vary by study. Pinealon is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Pinealon is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.